Replies to post #141335 on OWC Pharmaceutical Research Corp (OWCP)

[moxa1]

A shareholder called the company not too long ago and asked about the IRB study. His understanding was that they've already completed Phase I of the psoriasis safety study but the 2nd part, what he called Phase II won't be complete until Q3. They expect to report on progress very shortly, before the end of June IMO. I'm not sure if the "2nd" part is still part of the Phase I study or it's actually Phase II of the study. We should be hearing something very soon.